If you’d invested in: Bango and Vernalis
Bango creates technology that enables payments to be made via mobile phones. while Vernalis develops drugs.
If only
Cambridge-based Bango (Aim: BGO) develops technology that enables payments to be made via mobile phones. Bango collects a fee on each transaction made. Revenue was up by 200% in the year to 31 December, with strong growth predicted this year too. Losses narrowed to £4.6m from £5m the year before, and the firm expects to break even in the "near term", with profitability coming in the "medium term". The shares have risen by more than 150% in the last 12 months.
Be glad you didn't
Pharmaceutical firm Vernalis (Aim: VER) markets cough and cold medicine, antibiotics and migraine treatments in the US via its office in Pennsylvania, with more cough and cold products under development at its research centre in the UK. Latest interim results for the six months to
31 December showed losses rising and revenue falling. But the firm has plenty of cash and no debt. Investors have been abandoning the shares, however. The stock price is down by more than 50% in the last year.
Try 6 free issues of MoneyWeek today
Get unparalleled financial insight, analysis and expert opinion you can profit from.
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
-
One million more pensioners set to pay income tax in 2031 – how to lower your billHundreds of thousands of pensioners will be dragged into paying income tax due to an ongoing freeze to tax bands, forecasts suggest
-
Stock market circuit breaker: Why did Korean shares pause trading?The fallout from the conflict in the Middle East hit the Korean stock market on 4 March, with shares forced to temporarily stop trading. What is a stock market circuit breaker, and why did the KOSPI trigger one?
